Coley Pharmaceutical Group
Therapeutics and drug candidates to fight cancers, asthma, allergy and autoimmune disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD224m (Public information from Nov 2007)
Wellesley Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | - | |
$12.9m | Series B | ||
$7.0m | Series E | ||
$30.0m | Series F | ||
$25.2m | Series G | ||
$10.0m | Late VC | ||
| N/A | N/A | IPO | |
N/A | Debt | ||
$164m Valuation: $164m | Acquisition | ||
| Total Funding | CAD116m | ||